Wockhardt Ltd. (WOCKPHARMA): Wockhardt Share Price Rises 2.4% as Stock Trades at Rs 1,895.30
- September 2, 2026
- Posted by: Harsh Piplani
- Category: News
Wockhardt Share Price is trading at Rs 1,895.30, up 2.4% today, with market capitalisation at Rs 30,606.21 crore. The move has drawn attention in healthcare stock news even though the verified data does not establish a company-specific catalyst.
Wockhardt Share Price is in focus today after the stock rose 2.4% to Rs 1,895.30 from the previous close of Rs 1,850.85, adding Rs 44.45 in value during the ongoing session. The company’s market capitalisation stands at Rs 30,606.21 crore, keeping Wockhardt Ltd. among the more closely watched mid-to-large healthcare names in the Indian stock market. According to latest Univest data, the move is confirmed, while a company-specific catalyst is not established by the verified numbers. For readers tracking Wockhardt Share Price Today, the key question is not only the price rise but also how the stock’s premium valuation and weaker profitability ratios compare with the broader pharmaceutical universe.
Wockhardt Share Price Today: Price Action Analysis
In Wockhardt Stock News, the day’s range has been wide enough to attract short-term interest, and turnover of Rs 118.24 crore suggests active market participation without changing the core read on fundamentals. Univest is following the move as part of its live market update, with attention on what the price action says relative to sector peers, valuation benchmarks and the company’s profit-quality profile.
| Metric | Value |
|---|---|
| Current Price | Rs 1,895.3 |
| Previous Close | Rs 1,850.85 |
| Today's Move | Rs 44.45 (+2.4%) |
| Open | Rs 1,850.85 |
| High | Rs 1,901 |
| Low | Rs 1,837 |
| Turnover | Rs 118.24 crore |
| Market Capitalisation | Rs 30,606.21 crore |
| Market Cap Category | Large Cap |
Wockhardt Ltd. (WOCKPHARMA) rose to Rs 1,895.3 from the previous close of Rs 1,850.85, a move of Rs 44.45 or 2.4%. The stock opened at Rs 1,850.85, reached a high of Rs 1,901, recorded a low of Rs 1,837.
Wockhardt Share Price Today shows a clear same-day gain, with the stock opening at Rs 1,850.85, touching a high of Rs 1,901 and a low of Rs 1,837 before trading at Rs 1,895.30 at the time of this update. The rise of Rs 44.45, or 2.4%, places Wockhardt among the better-moving stocks in today’s healthcare market update. The latest Univest data confirms that the price event is real and measurable, even though no company-specific trigger is verified. For investors scanning Wockhardt Share Price Live, the main takeaway is simple: the stock is rising today on noticeable price action rather than on an explicitly identified news event.
This is the type of move that often brings Wockhardt Share News into focus on Stock Market Today searches, especially when the stock is already priced at a notable absolute level. Univest is treating the move as a price rise event first, with the next layer of analysis coming from valuation and sector comparison rather than speculation.
Wockhardt Ltd. (WOCKPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 30,606.21 crore |
| P/E Ratio | 73.53x |
| P/B Ratio | 5.97x |
| ROE | 4.29% |
| ROCE | 6.79% |
| EPS | Rs 25.17 |
| Book Value Per Share | Rs 309.81 |
| Dividend Yield | 0% |
Wockhardt Ltd. (WOCKPHARMA) fundamental metrics show P/E 73.53x, P/B 5.97x, ROE 4.29%, ROCE 6.79%. These figures provide context only and are not a buy or sell signal.
Wockhardt Ltd. has a market capitalisation of Rs 30606.21 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 73.53x, P/B at 5.97x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.29% and ROCE of 6.79%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 25.17, book value per share of Rs 309.81, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.29x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 73.53x |
| Benchmark Median P/E | 31.29x |
| Benchmark Average P/E | 48.12x |
| Benchmark P/E Range | 3.68x to 653.31x |
| Company P/B Ratio | 5.97x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 4.29% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 6.79% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 30,606.21 crore |
| Benchmark Median Market Cap | Rs 720.34 crore |
Wockhardt Ltd. (WOCKPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 73.53x, which is above the benchmark median of 31.29x, a difference of +135%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Wockhardt Ltd. (WOCKPHARMA) has a ROE of 4.29%, which is below the benchmark median of 11.79%, a difference of -63.61%. Wockhardt Ltd. (WOCKPHARMA) has a ROCE of 6.79%, which is below the benchmark median of 13.63%, a difference of -50.18%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,69,309.92 | 38.29 | 5.36 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,45,425.7 | 83.18 | 13.77 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,347.12 | 86.48 | 21.02 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,919.92 | 25.73 | 4.31 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,392.76 | 33.99 | 3.26 | 11.83 | 16 |
Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 73.53x compared with the displayed peer median of 38.29x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.29% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 6.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Wockhardt Ltd. (WOCKPHARMA) has a market capitalisation of Rs 30,606.21 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Wockhardt
- Wockhardt Share Price is trading higher today, making it a visible mover in healthcare stock news.
- The stock’s P/E of 73.53 and P/B of 5.97 keep valuation in focus for Wockhardt Share Price Today.
- ROE of 4.29% and ROCE of 6.79% show weaker return ratios than many peers.
- Market capitalisation of Rs 30,606.21 crore places the company well above the industry median size.
- Univest is tracking whether the latest price action is being matched by stronger financial performance over time.
About Wockhardt
Wockhardt Ltd. is a healthcare company in the Pharmaceuticals & Drugs industry, and its Wockhardt Share Price typically attracts attention when pharma names move sharply. The company is part of a sector where investors watch valuation, profitability and relative scale closely. With market capitalisation at Rs 30,606.21 crore, Wockhardt sits well above the benchmark median company size in its industry set.
From a business perspective, the company operates in a segment where product portfolio, regulatory execution and commercial reach are usually important to investor perception. For readers checking Wockhardt Stock News or Wockhardt Latest News, the current price rise is best understood as a market event layered on top of a business already priced at a premium versus the industry median. Univest keeps the stock on radar because such names often see sharper reactions when sentiment turns in their favour or when investors re-rate the sector.
Frequently Asked Questions
Why is Wockhardt Share Price rising today?
Ans. Wockhardt Share Price is up 2.4% today, but the verified numbers do not establish a company-specific catalyst. The move is confirmed through the price change, intraday range and turnover shown in latest Univest data.
What is Wockhardt Share Price today?
Ans. Wockhardt Share Price today is Rs 1,895.30. It is trading above the previous close of Rs 1,850.85 and has added Rs 44.45, which keeps Wockhardt Share Price Today in focus.
What is the market capitalisation of Wockhardt?
Ans. Wockhardt’s market capitalisation stands at Rs 30,606.21 crore. That places it far above the same-industry median market cap of Rs 720.34 crore and supports its relevance in healthcare stock news.
Is Wockhardt expensive compared with peers?
Ans. Wockhardt trades at a P/E of 73.53 and P/B of 5.97, both above the same-industry median. That suggests a premium valuation versus the broader pharmaceuticals & drugs benchmark.
How do Wockhardt’s profitability ratios compare with peers?
Ans. Wockhardt has ROE of 4.29% and ROCE of 6.79%, both below the industry median and average. Several peers, including Zydus Lifesciences and Lupin, show stronger return ratios. The relevant peer median ROE is 11.79%.
What are Wockhardt EPS and book value?
Ans. Wockhardt EPS is Rs 25.17 and book value is Rs 309.81 per share. EPS shows earnings per share, while book value indicates accounting net worth behind each share.
Does Wockhardt pay a dividend?
Ans. Wockhardt’s dividend yield is 0. That means the current snapshot does not show a dividend return, so investors are mainly focusing on price action, valuation and business performance.
How should investors read Wockhardt Share Price news today?
Ans. Wockhardt Share Price news today combines a 2.4% rise with a premium valuation and softer return ratios. Univest views it as a stock worth tracking for price action and sector comparison.
Track Wockhardt Share Price on Univest
Use Wockhardt Ltd. (WOCKPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Wockhardt Share Price on Univest for live price updates, Wockhardt Share Price Today, valuation ratios, company financials, 52-week levels and market insights in one place. Univest also helps readers follow Wockhardt Stock Performance alongside peer context, so the day’s move can be judged against both sector benchmarks and broader stock updates.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
